Hemodynamic effects of the somatostatin analog lanreotide in humans: placebo-controlled, cross-over dose-ranging Echo-Doppler study (Q32069134)

6 July 2017

title

Hemodynamic effects of the somatostatin analog lanreotide in humans: placebo-controlled, cross-over dose-ranging Echo-Doppler study (English)

1 reference

6 July 2017

0 references

1 reference

C Mottet

1

1 reference

6 July 2017

C C Sieber

2

1 reference

6 July 2017

A Nauer

3

1 reference

6 July 2017

J Drewe

4

1 reference

6 July 2017

R Fried

5

1 reference

6 July 2017

F Larsen

6

1 reference

6 July 2017

C Beglinger

7

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

6 July 2017

1 reference

6 July 2017

volume

27

1 reference

6 July 2017

issue

4

1 reference

6 July 2017

page(s)

920-925

1 reference

Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270405

7 January 2021

Octreotide infusion or emergency sclerotherapy for variceal haemorrhage

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270405

7 January 2021

Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Variceal Bleeding Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270405

7 January 2021

Haemodynamic effects of a long-acting somatostatin analogue in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270405

7 January 2021

Enhancement of renal function by a long-acting somatostatin analogue in patients with decompensated cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270405

7 January 2021

Regulation of postprandial mesenteric blood flow in humans: evidence for a cholinergic nervous reflex

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270405

7 January 2021

A randomized study of propranolol on postprandial portal hyperemia in cirrhotic patients.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270405

7 January 2021

Postprandial hemodynamic responses in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270405

7 January 2021

The effect of non-protein liquid meals on the hepatic venous pressure gradient in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270405

7 January 2021

Fasting and post-prandial splanchnic blood flow is reduced by a somatostatin analogue (octreotide) in man

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270405

7 January 2021

The peptide release inhibitor, Octreotide (SMS 201-995), prevents the haemodynamic changes following food ingestion in normal human subjects.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270405

7 January 2021

Octreotide inhibits the meal-induced increases in the portal venous pressure of cirrhotic patients with portal hypertension: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270405

7 January 2021

Octreotide prevents postprandial splanchnic hyperemia in patients with portal hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270405

7 January 2021

Pharmacokinetic and pharmacodynamic properties of a long-acting formulation of the new somatostatin analogue, lanreotide, in normal healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270405

7 January 2021

Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270405

7 January 2021

Long-term octreotide treatment prevents vascular hyporeactivity in portal-hypertensive rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270405

7 January 2021

Intestinal phase of superior mesenteric artery blood flow in man

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270405

7 January 2021

The effect of meal size on postprandial increase in cardiac output

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270405

7 January 2021

Conversion between permeability states of IP3 receptors in cultured smooth muscle cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270405

7 January 2021

Identifiers

DOI

10.1002/HEP.510270405

1 reference

6 July 2017

1 reference